BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196905. A total of 5 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,063,000 | +315.2% | 124 | +254.3% | 0.04% | +122.2% |
Q2 2020 | $256,000 | -79.3% | 35 | -90.4% | 0.02% | -82.5% |
Q1 2020 | $1,239,000 | -40.7% | 364 | -5.2% | 0.10% | -43.4% |
Q4 2019 | $2,090,000 | -25.3% | 384 | -42.8% | 0.18% | -29.2% |
Q3 2019 | $2,799,000 | -24.7% | 671 | -21.0% | 0.26% | -24.0% |
Q2 2019 | $3,718,000 | +65.3% | 849 | +94.3% | 0.34% | +55.0% |
Q1 2019 | $2,249,000 | +119.8% | 437 | +10.1% | 0.22% | +80.2% |
Q1 2018 | $1,023,000 | +143.0% | 397 | +154.5% | 0.12% | +95.2% |
Q4 2017 | $421,000 | -59.9% | 156 | -44.5% | 0.06% | -64.6% |
Q3 2017 | $1,050,000 | – | 281 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BOOTHBAY FUND MANAGEMENT, LLC | 156 | $421,000 | 0.06% |